| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ATVB In Focus |
From the Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY.
Correspondence to Michael P. Lisanti, Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Ave, Golding 202, Bronx, NY 10461. E-mail lisanti{at}aecom.yu.edu
Caveolae are 50- to 100-nm cell-surface plasma membrane invaginations observed in terminally differentiated cells. They are particularly abundant in endothelial cells, where they are believed to play a major role in the regulation of endothelial vesicular trafficking and signal transduction. The use of caveolin-1deficient mice has provided many new insights into the roles of caveolae and caveolin-1 in the regulation of endothelial cell function. These novel findings suggest an important role for caveolin-1 in the pathogenesis of cancer, atherosclerosis, and vascular disease.
Key Words: caveolae endothelial cells transcytosis angiogenesis atherosclerosis
This article has been cited by other articles:
![]() |
J. Igarashi, K. Shoji, T. Hashimoto, T. Moriue, K. Yoneda, T. Takamura, T. Yamashita, Y. Kubota, and H. Kosaka Transforming growth factor-{beta}1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1263 - C1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Chang, D. Feng, J. A. Nagy, T. E. Sciuto, A. M. Dvorak, and H. F. Dvorak Vascular Permeability and Pathological Angiogenesis in Caveolin-1-Null Mice Am. J. Pathol., October 1, 2009; 175(4): 1768 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Stamatovic, R. F. Keep, M. M. Wang, I. Jankovic, and A. V. Andjelkovic Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial Cells J. Biol. Chem., July 10, 2009; 284(28): 19053 - 19066. [Abstract] [Full Text] [PDF] |
||||
|
|
L. Gotloib HISTOLOGY IN EXPERIMENTAL PERITONEAL DIALYSIS: THE LINK BETWEEN STRUCTURE AND FUNCTION Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S36 - S39. [Full Text] [PDF] |
||||
![]() |
G. Lenz, G. Wright, S.S. Dave, W. Xiao, J. Powell, H. Zhao, W. Xu, B. Tan, N. Goldschmidt, J. Iqbal, et al. Stromal Gene Signatures in Large-B-Cell Lymphomas N. Engl. J. Med., November 27, 2008; 359(22): 2313 - 2323. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Frank and M. P. Lisanti ICAM-1: role in inflammation and in the regulation of vascular permeability Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H926 - H927. [Full Text] [PDF] |
||||
![]() |
V. C. Cogger, I. M. Arias, A. Warren, A. C. McMahon, D. L. Kiss, V. M. Avery, and D. G. Le Couteur The response of fenestrations, actin, and caveolin-1 to vascular endothelial growth factor in SK Hep1 cells Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G137 - G145. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Imamura, R. Takahashi, R. Murakami, H. Kataoka, X. W. Cheng, Y. Numaguchi, T. Murohara, and K. Okumura The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels Eur. J. Endocrinol., February 1, 2008; 158(2): 189 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Tahir, G. Yang, A. A. Goltsov, M. Watanabe, K.-i. Tabata, J. Addai, E. M. A. Fattah, D. Kadmon, and T. C. Thompson Tumor Cell-Secreted Caveolin-1 Has Proangiogenic Activities in Prostate Cancer Cancer Res., February 1, 2008; 68(3): 731 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Lim, E. J. Smart, M. Toborek, and B. Hennig The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3340 - H3347. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Prakash, M. A. Thompson, B. Vaa, I. Matabdin, T. E. Peterson, T. He, and C. M. Pabelick Caveolins and intracellular calcium regulation in human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1118 - L1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. DeWever, F. Frerart, C. Bouzin, C. Baudelet, R. Ansiaux, P. Sonveaux, B. Gallez, C. Dessy, and O. Feron Caveolin-1 Is Critical for the Maturation of Tumor Blood Vessels through the Regulation of Both Endothelial Tube Formation and Mural Cell Recruitment Am. J. Pathol., November 1, 2007; 171(5): 1619 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, V. Rizzo, Y. Liu, I. M. Sainz, N. G. Schmuckler, and R. W. Colman Kininostatin Associates With Membrane Rafts and Inhibits {alpha}v{beta}3 Integrin Activation in Human Umbilical Vein Endothelial Cells Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1968 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Awasthi, S. K. Mandal, V. Papanna, L. V. M. Rao, and U. R. Pendurthi Modulation of Tissue Factor-Factor VIIa Signaling by Lipid Rafts and Caveolae Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1447 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Giulivi, K. Kato, and C. E. Cooper Nitric oxide regulation of mitochondrial oxygen consumption I: cellular physiology Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1225 - C1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Komers, W. E. Schutzer, J. F. Reed, J. N. Lindsley, T. T. Oyama, D. C. Buck, S. L. Mader, and S. Anderson Altered Endothelial Nitric Oxide Synthase Targeting and Conformation and Caveolin-1 Expression in the Diabetic Kidney Diabetes, June 1, 2006; 55(6): 1651 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, H. Liao, X. Xie, Y. Yuan, T.-S. Lee, N. Wang, X. Wang, J. Y.-J. Shyy, and M. B. Stemerman Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR) Cardiovasc Res, December 1, 2005; 68(3): 425 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-b. Chen, S.-m. Li, X.-X. Qian, C. Moon, and J. Zheng Tyrosine Phosphorylation of Caveolin 1 by Oxidative Stress Is Reversible and Dependent on the c-src Tyrosine Kinase but Not Mitogen-Activated Protein Kinase Pathways in Placental Artery Endothelial Cells Biol Reprod, October 1, 2005; 73(4): 761 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. NAVARRO, B. ANAND-APTE, and M.-O. PARAT A role for caveolae in cell migration FASEB J, December 1, 2004; 18(15): 1801 - 1811. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Pearson Caveolae and EDHF production Cardiovasc Res, November 1, 2004; 64(2): 189 - 191. [Full Text] [PDF] |
||||
![]() |
A. Graziani, V. Bricko, M. Carmignani, W. F. Graier, and K. Groschner Cholesterol- and caveolin-rich membrane domains are essential for phospholipase A2-dependent EDHF formation Cardiovasc Res, November 1, 2004; 64(2): 234 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Endemann and E. L. Schiffrin Endothelial Dysfunction J. Am. Soc. Nephrol., August 1, 2004; 15(8): 1983 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sonveaux, P. Martinive, J. DeWever, Z. Batova, G. Daneau, M. Pelat, P. Ghisdal, V. Gregoire, C. Dessy, J.-L. Balligand, et al. Caveolin-1 Expression Is Critical for Vascular Endothelial Growth Factor-Induced Ischemic Hindlimb Collateralization and Nitric Oxide-Mediated Angiogenesis Circ. Res., July 23, 2004; 95(2): 154 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.D. Norata, E. Callegari, H. Inoue, and A.L. Catapano HDL3 Induces Cyclooxygenase-2 Expression and Prostacyclin Release in Human Endothelial Cells Via a p38 MAPK/CRE-Dependent Pathway: Effects on COX-2/PGI-Synthase Coupling Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 871 - 877. [Abstract] [Full Text] |
||||
![]() |
Y. van Hensbergen, H. J. Broxterman, S. Rana, P. J. van Diest, M. C. A. Duyndam, K. Hoekman, H. M. Pinedo, and E. Boven Reduced Growth, Increased Vascular Area, and Reduced Response to Cisplatin in CD13-Overexpressing Human Ovarian Cancer Xenografts Clin. Cancer Res., February 1, 2004; 10(3): 1180 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Frank, H. Lee, D. S. Park, N. N. Tandon, P. E. Scherer, and M. P. Lisanti Genetic Ablation of Caveolin-1 Confers Protection Against Atherosclerosis Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 98 - 105. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |